Literature DB >> 16376669

Cytomegalovirus retinitis after intravitreous triamcinolone in an immunocompetent patient.

Michael A Saidel1, John Berreen, Todd P Margolis.   

Abstract

PURPOSE: To report the case of a 75-year-old man with diabetes who developed cytomegalovirus (CMV) retinitis after intravitreous injection of triamcinolone acetonide (IVTA).
DESIGN: Observational case report.
METHODS: Review of medical records.
RESULTS: A 75-year-old man with diabetic macular edema developed arcuate retinal whitening after IVTA. A presumptive diagnosis of viral retinitis was made, and a vitrectomy was performed. Polymerase chain reaction of the vitreous was positive for CMV DNA. An infectious disease consultant found no signs of systemic CMV infection, and laboratory examination revealed that the patient was HIV negative. The patient responded well to intravitreal ganciclovir and oral valganciclovir, but when therapy was discontinued, the retinitis recurred and CMV DNA was again detected in the vitreous. The retinitis once again responded to antiviral therapy.
CONCLUSIONS: CMV retinitis can occur after local immunosuppression with IVTA. Clinicians should be aware of this rare complication of IVTA.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16376669     DOI: 10.1016/j.ajo.2005.06.058

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  31 in total

1.  Cytomegalovirus retinitis after subtenon triamcinolone acetonide and intravitreal injection of anti-vascular endothelial growth factor in an immunocompetent patient with age-related macular degeneration and diabetes mellitus.

Authors:  Noriko Toyokawa; Hideya Kimura; Shinichiro Kuroda
Journal:  Jpn J Ophthalmol       Date:  2010-04-18       Impact factor: 2.447

2.  Viral retinitis after intravitreal triamcinolone injection in patients with predisposing medical comorbidities.

Authors:  Ankur M Shah; Stephen F Oster; William R Freeman
Journal:  Am J Ophthalmol       Date:  2010-03       Impact factor: 5.258

3.  Hypertensive iridocyclitis.

Authors:  E C Kim; T P Margolis
Journal:  Br J Ophthalmol       Date:  2006-07       Impact factor: 4.638

4.  Cytomegalovirus retinitis after intravitreal triamcinolone acetonide in an immunocompetent patient.

Authors:  Sekiryu Tetsuju; Tomohiro Iida; Hisatoshi Kaneko; Masaaki Saito
Journal:  Jpn J Ophthalmol       Date:  2008-11-11       Impact factor: 2.447

Review 5.  Viral retinitis following intraocular or periocular corticosteroid administration: a case series and comprehensive review of the literature.

Authors:  Ako Takakura; Howard H Tessler; Debra A Goldstein; Yan Guex-Crosier; Chi-Chao Chan; Diane M Brown; Jennifer E Thorne; Robert Wang; Emmett T Cunningham
Journal:  Ocul Immunol Inflamm       Date:  2014-03-21       Impact factor: 3.070

Review 6.  Viral posterior uveitis.

Authors:  Joanne H Lee; Aniruddha Agarwal; Padmamalini Mahendradas; Cecilia S Lee; Vishali Gupta; Carlos E Pavesio; Rupesh Agrawal
Journal:  Surv Ophthalmol       Date:  2016-12-22       Impact factor: 6.048

7.  Cytomegalovirus retinitis after low-dose intravitreous triamcinolone acetonide in an immunocompetent patient: a warning for the widespread use of intravitreous corticosteroids.

Authors:  Dora Vertes; Bernadette Snyers; Patrick De Potter
Journal:  Int Ophthalmol       Date:  2010-10-08       Impact factor: 2.031

8.  Outcome of cytomegalovirus retinitis in immunocompromised patients without Human Immunodeficiency Virus treated with intravitreal ganciclovir injection.

Authors:  Aniruddha Agarwal; Neha Kumari; Amita Trehan; Alka Khadwal; Mangat R Dogra; Vishali Gupta; Aman Sharma; Amod Gupta; Ramandeep Singh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-02-21       Impact factor: 3.117

Review 9.  Acute retinal necrosis by cytomegalovirus in an immunocompetent adult: case report and review of the literature.

Authors:  I Tajunisah; S C Reddy; L H Tan
Journal:  Int Ophthalmol       Date:  2007-11-16       Impact factor: 2.031

10.  Cytomegalovirus retinitis after intravitreous triamcinolone injection in a patient with central retinal vein occlusion.

Authors:  Yong Sik Park; Suk Ho Byeon
Journal:  Korean J Ophthalmol       Date:  2008-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.